Personalised Insulin Adjustment with Reinforcement Learning: An In-Silico Validation for People with Diabetes on Intensive Insulin Treatment

• URL: http://arxiv.org/abs/2505.14477v1
• Date: Tue, 20 May 2025 15:10:06 GMT
• Title: Personalised Insulin Adjustment with Reinforcement Learning: An In-Silico Validation for People with Diabetes on Intensive Insulin Treatment
• Authors: Maria Panagiotou, Lorenzo Brigato, Vivien Streit, Amanda Hayoz, Stephan Proennecke, Stavros Athanasopoulos, Mikkel T. Olsen, Elizabeth J. den Brok, Cecilie H. Svensson, Konstantinos Makrilakis, Maria Xatzipsalti, Andriani Vazeou, Peter R. Mertens, Ulrik Pedersen-Bjergaard, Bastiaan E. de Galan, Stavroula Mougiakakou,
• Abstract summary: Adaptive Basal-Bolus Advisor (ABBA) is a personalised insulin treatment recommendation approach based on reinforcement learning.<n>We developed and evaluated the ability of ABBA to achieve better time-in-range for individuals with type 1 diabetes (T1D) and type 2 diabetes (T2D)<n>Our results warrant ABBA to be trialed for the first time in humans.
• Score: 0.0
• License: http://creativecommons.org/licenses/by/4.0/
• Abstract: Despite recent advances in insulin preparations and technology, adjusting insulin remains an ongoing challenge for the majority of people with type 1 diabetes (T1D) and longstanding type 2 diabetes (T2D). In this study, we propose the Adaptive Basal-Bolus Advisor (ABBA), a personalised insulin treatment recommendation approach based on reinforcement learning for individuals with T1D and T2D, performing self-monitoring blood glucose measurements and multiple daily insulin injection therapy. We developed and evaluated the ability of ABBA to achieve better time-in-range (TIR) for individuals with T1D and T2D, compared to a standard basal-bolus advisor (BBA). The in-silico test was performed using an FDA-accepted population, including 101 simulated adults with T1D and 101 with T2D. An in-silico evaluation shows that ABBA significantly improved TIR and significantly reduced both times below- and above-range, compared to BBA. ABBA's performance continued to improve over two months, whereas BBA exhibited only modest changes. This personalised method for adjusting insulin has the potential to further optimise glycaemic control and support people with T1D and T2D in their daily self-management. Our results warrant ABBA to be trialed for the first time in humans.

Related papers

• Insulin Resistance Prediction From Wearables and Routine Blood Biomarkers [44.735350554750916]
  We remotely recruited the largest dataset to date across the US to study insulin resistance.<n>Deep neural network models were developed to predict insulin resistance based on readily available digital and blood biomarkers.<n>Model showed 93% sensitivity and 95% adjusted specificity in obese and sedentary participants.
  arXiv  Detail & Related papers  (2025-04-30T16:10:20Z)
• BalancedDPO: Adaptive Multi-Metric Alignment [44.051100004689296]
  We present BalancedDPO, a novel extension of Direct Preference Optimization (DPO)<n>We simultaneously align T2I diffusion models with multiple metrics, including human preference, CLIP score, and aesthetic quality.<n>Our evaluations show that BalancedDPO achieves state-of-the-art results, outperforming existing approaches across all major metrics.
  arXiv  Detail & Related papers  (2025-03-16T17:06:00Z)
• Finetuning and Quantization of EEG-Based Foundational BioSignal Models on ECG and PPG Data for Blood Pressure Estimation [53.2981100111204]
  Photoplethysmography and electrocardiography can potentially enable continuous blood pressure (BP) monitoring.<n>Yet accurate and robust machine learning (ML) models remains challenging due to variability in data quality and patient-specific factors.<n>In this work, we investigate whether a model pre-trained on one modality can effectively be exploited to improve the accuracy of a different signal type.<n>Our approach achieves near state-of-the-art accuracy for diastolic BP and surpasses by 1.5x the accuracy of prior works for systolic BP.
  arXiv  Detail & Related papers  (2025-02-10T13:33:12Z)
• T2-Only Prostate Cancer Prediction by Meta-Learning from Bi-Parametric MR Imaging [39.64252838533947]
  Current imaging-based prostate cancer diagnosis requires both MR T2-weighted (T2w) and diffusion-weighted imaging (DWI) sequences. measuring diffusion patterns in DWI sequences can be time-consuming, prone to artifacts and sensitive to imaging parameters. This study investigates the potential of machine learning (ML) methods using only the T2w sequence as input during inference time.
  arXiv  Detail & Related papers  (2024-11-11T22:38:45Z)
• CLIP-DR: Textual Knowledge-Guided Diabetic Retinopathy Grading with Ranking-aware Prompting [48.47935559597376]
  Diabetic retinopathy (DR) is a complication of diabetes and usually takes decades to reach sight-threatening levels. Most current DR grading methods suffer from insufficient robustness to data variability. We propose a novel DR grading framework CLIP-DR based on three observations.
  arXiv  Detail & Related papers  (2024-07-04T17:14:18Z)
• Attention Networks for Personalized Mealtime Insulin Dosing in People with Type 1 Diabetes [0.30723404270319693]
  We demonstrate how a reinforcement learning agent, employing a self-attention encoder network, can effectively mimic and enhance this intuitive process. Results reveal a significant reduction in glycemic risk, from 16.5 to 9.6 in scenarios using sensor-augmented pump and from 9.1 to 6.7 in scenarios using automated insulin delivery.
  arXiv  Detail & Related papers  (2024-06-18T17:59:32Z)
• Supervised Learning Models for Early Detection of Albuminuria Risk in Type-2 Diabetes Mellitus Patients [0.0]
  This study aimed to develop a supervised learning model to predict the risk of developing albuminuria in T2DM patients. It consisted of 10 attributes as features and 1 attribute as the target (albuminuria) It achieved accuracy and f1-score values as high as 0.74 and 0.75, respectively, making it suitable for screening purposes in predicting albuminuria in T2DM.
  arXiv  Detail & Related papers  (2023-09-28T08:41:12Z)
• Using Reinforcement Learning to Simplify Mealtime Insulin Dosing for People with Type 1 Diabetes: In-Silico Experiments [0.40792653193642503]
  People with type 1 diabetes (T1D) struggle to calculate the optimal insulin dose at mealtime. We propose an RL agent that recommends the optimal meal-accompanying insulin dose corresponding to a qualitative meal (QM) strategy.
  arXiv  Detail & Related papers  (2023-09-17T01:34:02Z)
• A novel solution of deep learning for enhanced support vector machine for predicting the onset of type 2 diabetes [32.25039205521283]
  This research aims to increase the accuracy and Area Under the Curve (AUC) metric while improving the processing time for predicting the onset of Type 2 Diabetes. The proposed solution provides an average accuracy of 86.31 % and an average AUC value of 0.8270 or 82.70 %, with an improvement of 3.8 milliseconds in the processing.
  arXiv  Detail & Related papers  (2022-08-05T18:15:40Z)
• Building Brains: Subvolume Recombination for Data Augmentation in Large Vessel Occlusion Detection [56.67577446132946]
  A large training data set is required for a standard deep learning-based model to learn this strategy from data. We propose an augmentation method that generates artificial training samples by recombining vessel tree segmentations of the hemispheres from different patients. In line with the augmentation scheme, we use a 3D-DenseNet fed with task-specific input, fostering a side-by-side comparison between the hemispheres.
  arXiv  Detail & Related papers  (2022-05-05T10:31:57Z)
• Task-wise Split Gradient Boosting Trees for Multi-center Diabetes Prediction [37.846368153741395]
  Task-wise Split Gradient Boosting Trees (TSGB) is proposed for the multi-center diabetes prediction task. TSGB achieves superior performance against several state-of-the-art methods. The proposed TSGB method has been deployed as an online diabetes risk assessment software for early diagnosis.
  arXiv  Detail & Related papers  (2021-08-16T14:22:44Z)
• A Benchmark for Studying Diabetic Retinopathy: Segmentation, Grading, and Transferability [76.64661091980531]
  People with diabetes are at risk of developing diabetic retinopathy (DR) Computer-aided DR diagnosis is a promising tool for early detection of DR and severity grading. This dataset has 1,842 images with pixel-level DR-related lesion annotations, and 1,000 images with image-level labels graded by six board-certified ophthalmologists.
  arXiv  Detail & Related papers  (2020-08-22T07:48:04Z)
• Challenging common bolus advisor for self-monitoring type-I diabetes patients using Reinforcement Learning [0.0]
  Patients with diabetes who are self-monitoring have to decide right before each meal how much insulin they should take. We challenged this rule applying Reinforcement Learning techniques on data simulated with T1DM, an FDA-approved simulator.
  arXiv  Detail & Related papers  (2020-07-23T09:38:54Z)
• Basal Glucose Control in Type 1 Diabetes using Deep Reinforcement Learning: An In Silico Validation [16.93692520921499]
  We propose a novel deep reinforcement learning model for single-hormone (insulin) and dual-hormone (insulin and glucagon) delivery. In the adult cohort, percentage time in target range improved from 77.6% to 80.9% with single-hormone control. In the adolescent cohort, percentage time in target range improved from 55.5% to 65.9% with single-hormone control.
  arXiv  Detail & Related papers  (2020-05-18T20:13:16Z)

This list is automatically generated from the titles and abstracts of the papers in this site.

This site does not guarantee the quality of this site (including all information) and is not responsible for any consequences.